Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Find Roth IRA index funds with the lowest fees to keep more of your returns. Compare expense ratios and pick a cost-efficient fund for long-term growth.
27,085 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
The Trade Desk surged after a large insider purchase by its CEO, lifting the stock among S&P 500 movers as Palantir a...
Rivian readies its lower-cost R2 for April deliveries, a pivotal move as analysts weigh its power to expand beyond pr...
Oil-driven volatility keeps the S&P 500 near unchanged on March 11, 2026, as traders weigh supply risks and central-b...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
A recent SEC filing shows Tabor Asset Management increasing its stake in Madison Square Garden Sports, underscoring a...
Oil prices climbed after OPEC+ extended production cuts, pushing Brent above $100 as of March 13, 2026. The current p...
As autonomous driving heats up, two stocks stand out as potential multibagger candidates by 2030. This article breaks...
A wave of zero-emission school bus mandates is accelerating across several states, putting districts under budget pre...
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
Rivian shares surged about 8% after the company unveiled the R2 midsize SUV, signaling a push toward broader market a...
Young graduates facing scarce first jobs as data show the entry-level market worst it’s unfolding despite a steadier ...